Financials Wooree Bio Co.,Ltd

Equities

A082850

KR7082850009

Semiconductors

End-of-day quote Korea S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
2,560 KRW -0.78% Intraday chart for Wooree Bio Co.,Ltd +1.59% -22.54%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 33,786 48,909 268,562 204,033 140,242 155,954
Enterprise Value (EV) 1 159,795 152,471 297,029 201,741 116,248 117,343
P/E ratio -1.03 x 10.5 x 16.4 x 6.35 x 6.4 x 10 x
Yield - - - - - -
Capitalization / Revenue 0.03 x 0.03 x 0.17 x 0.13 x 0.1 x 0.12 x
EV / Revenue 0.12 x 0.09 x 0.18 x 0.13 x 0.09 x 0.09 x
EV / EBITDA 8.03 x 2.37 x 3.89 x 2.59 x 1.65 x 2.03 x
EV / FCF -16 x 2.34 x 5.74 x 11.2 x 6.43 x 11.5 x
FCF Yield -6.25% 42.8% 17.4% 8.93% 15.5% 8.73%
Price to Book 0.38 x 0.52 x 2.42 x 1.32 x 0.78 x 0.78 x
Nbr of stocks (in thousands) 40,269 43,669 43,669 45,747 46,747 47,187
Reference price 2 839.0 1,120 6,150 4,460 3,000 3,305
Announcement Date 3/25/19 3/19/20 3/22/21 3/22/22 3/22/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,279,627 1,672,648 1,623,383 1,543,312 1,355,056 1,263,944
EBITDA 1 19,901 64,376 76,287 77,974 70,435 57,832
EBIT 1 -13,700 24,325 37,442 42,417 34,241 25,982
Operating Margin -1.07% 1.45% 2.31% 2.75% 2.53% 2.06%
Earnings before Tax (EBT) 1 -29,201 10,397 22,224 45,281 32,026 21,729
Net income 1 -32,888 4,532 16,841 33,156 21,822 15,581
Net margin -2.57% 0.27% 1.04% 2.15% 1.61% 1.23%
EPS 2 -816.7 106.4 376.0 702.1 469.0 329.0
Free Cash Flow 1 -9,986 65,297 51,768 18,010 18,074 10,243
FCF margin -0.78% 3.9% 3.19% 1.17% 1.33% 0.81%
FCF Conversion (EBITDA) - 101.43% 67.86% 23.1% 25.66% 17.71%
FCF Conversion (Net income) - 1,440.92% 307.39% 54.32% 82.83% 65.74%
Dividend per Share - - - - - -
Announcement Date 3/25/19 3/19/20 3/22/21 3/22/22 3/22/23 3/20/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 126,009 103,562 28,467 - - -
Net Cash position 1 - - - 2,292 23,994 38,611
Leverage (Debt/EBITDA) 6.332 x 1.609 x 0.3732 x - - -
Free Cash Flow 1 -9,986 65,297 51,768 18,010 18,074 10,243
ROE (net income / shareholders' equity) -23% 4.93% 12.5% 25.6% 11.8% 7.93%
ROA (Net income/ Total Assets) -1.41% 2.5% 3.73% 4.05% 3.5% 2.84%
Assets 1 2,340,254 181,106 451,994 819,469 623,677 549,082
Book Value Per Share 2 2,185 2,138 2,545 3,387 3,829 4,228
Cash Flow per Share 2 453.0 837.0 1,274 1,877 1,414 1,276
Capex 1 28,037 24,114 17,259 11,620 13,268 10,497
Capex / Sales 2.19% 1.44% 1.06% 0.75% 0.98% 0.83%
Announcement Date 3/25/19 3/19/20 3/22/21 3/22/22 3/22/23 3/20/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A082850 Stock
  4. Financials Wooree Bio Co.,Ltd